It is also possible that some polymorphisms in the amyloid pathway may be inversely associated with cancer and AD; peptidylprolyl cis/trans isomerase, NIMA-interacting 1 (PIN1) has been proposed as one such candidate (Balastik et al., 2007; Driver and Lu, 2010). This evidence concerns the gene PIN1 and cancer.